Advertisement
Advertisement

BCDA

BCDA logo

BioCardia, Inc. Common Stock

1.11
USD
Sponsored
+0.02
+1.83%
May 08, 15:58 UTC -4
Closed
exchange

After-Market

1.08

-0.03
-2.70%

BioCardia, Inc. Common Stock Profile

About

BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California.

Info & Links

CEO

Peter Altman

Headquarters

320 Soquel Way
Sunnyvale, CA 94085, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

http://www.biocardia.com

Auditor

PKF San Diego, LLP

Share holders

154

Employees

17

BioCardia, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

11.82M

Enterprise Value

9.32M

Enterprise Value/EBITDA(ttm)

-1.13

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

13.87

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-28372.40%

Return on Invested Capital(ttm)

8.94%

Return on Assets(ttm)

-238.22%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-8.25M

Net Income Available to Common(ttm)

-8.23M

Diluted EPS(ttm)

-1.29

Share Statistics

Beta (5Y Monthly)

0.55

52-Week Change

-61.05%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

10.94M

Dividend Yield

0.00%

Float4

9.04M

% Held by Insiders

17.40%

% Held by Institutions

20.57%

Balance Sheet

Total Cash(mrq)

2.50M

Total Cash Per Share(mrq)

0.23

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.12%

Quick Ratio(mrq)

1.12%

Book Value Per Share(mrq)

0.08

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.12

Free Cash Flow(ytd)

-7.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement